Delivery Order SPE2DB22D2005-SPE2DB25FJRB4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,741.85 to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Lotion in 60ml units. This contract award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $5,047.91 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Clindamycin Phosphate 1% Lotion (60 mL) under a firm fixed-price contract. This delivery order, which is not subject to any set-aside designation, is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $122,370 delivery order to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. The order was placed under an existing prime vendor contract vehicle to supply various pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 11-12, 2023. The pricing for this firm fixed price order is not...
- The Defense Logistics Agency awarded a $248,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. The contract has a period of performance of one day, from July 13 to July 14, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, any applicable government-wide acquisition contracts, or subcontractors. The...
- The Defense Logistics Agency awarded a $122,050 delivery order to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. The contract has a period of performance from July 13, 2023 through July 14, 2023 and utilizes a firm fixed price payment structure. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, major subcontractors, or set aside designations....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred seventy-two thousand forty-two dollars to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. The contract supports DLA's medical supply chain needs and calls for delivery of the pharmaceutical product to a facility in Conshohocken, Pennsylvania within the period of performance from June 21, 2023 to June 22, 2023. Amerisourcebergen will perform as the prime contractor...
- The Defense Logistics Agency awarded a $57,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. As the prime contractor, Amerisourcebergen Drug Corporation will supply the Defense Logistics Agency with 4561773122 units of 1-5% 25gm clindamycin-benzoyl peroxide gel to be delivered to its Conshohocken, Pennsylvania facility by August 11, 2023. The single award delivery order was placed against an existing DLA contract vehicle but...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $2,491.58 for Clindamycin Phosphate 1% Foam 50GM, a topical antibiotic medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a firm fixed-price procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,910 to Amerisourcebergen Drug Corporation for clindamycin-benzoyl peroxide topical gel. The contract has a period of performance from July 11, 2023 through July 12, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring...
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRB4Delivery Order
The Defense Logistics Agency awarded a $2,124.67 delivery order to AmerisourceBergen Drug Corp for clindamycin with benzoyl peroxide 1.2-5% topical solution (45 grams) under a firm fixed price contract. This non-competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical procurement fulfilling military and federal healthcare supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling AmerisourceBergen to supply a broad portfolio of medications, vaccines, medical devices, and specialty pharmaceuticals to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen demonstrates sustained capability to meet federal procurement requirements through its extensive experience delivering both brand-name and generic medications across multiple therapeutic domains to support military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/7/25 |